Translation deregulation in human disease
- PMID: 30038383
- DOI: 10.1038/s41580-018-0034-x
Translation deregulation in human disease
Abstract
Advances in sequencing and high-throughput techniques have provided an unprecedented opportunity to interrogate human diseases on a genome-wide scale. The list of disease-causing mutations is expanding rapidly, and mutations affecting mRNA translation are no exception. Translation (protein synthesis) is one of the most complex processes in the cell. The orchestrated action of ribosomes, tRNAs and numerous translation factors decodes the information contained in mRNA into a polypeptide chain. The intricate nature of this process renders it susceptible to deregulation at multiple levels. In this Review, we summarize current evidence of translation deregulation in human diseases other than cancer. We discuss translation-related diseases on the basis of the molecular aberration that underpins their pathogenesis (including tRNA dysfunction, ribosomopathies, deregulation of the integrated stress response and deregulation of the mTOR pathway) and describe how deregulation of translation generates the phenotypic variability observed in these disorders.
Similar articles
-
Protein translation: biological processes and therapeutic strategies for human diseases.Signal Transduct Target Ther. 2024 Feb 23;9(1):44. doi: 10.1038/s41392-024-01749-9. Signal Transduct Target Ther. 2024. PMID: 38388452 Free PMC article. Review.
-
Translation matters: protein synthesis defects in inherited disease.Nat Rev Genet. 2007 Sep;8(9):711-23. doi: 10.1038/nrg2142. Epub 2007 Jul 31. Nat Rev Genet. 2007. PMID: 17680008 Review.
-
The epitranscriptome in translation regulation: mRNA and tRNA modifications as the two sides of the same coin?FEBS Lett. 2019 Jul;593(13):1483-1493. doi: 10.1002/1873-3468.13491. Epub 2019 Jun 27. FEBS Lett. 2019. PMID: 31206634 Review.
-
Exploring contacts of eRF1 with the 3'-terminus of the P site tRNA and mRNA stop signal in the human ribosome at various translation termination steps.Biochim Biophys Acta Gene Regul Mech. 2017 Jul;1860(7):782-793. doi: 10.1016/j.bbagrm.2017.04.004. Epub 2017 Apr 27. Biochim Biophys Acta Gene Regul Mech. 2017. PMID: 28457996
-
Ribosome profiling and dynamic regulation of translation in mammals.Curr Opin Genet Dev. 2017 Apr;43:120-127. doi: 10.1016/j.gde.2017.03.005. Epub 2017 Mar 28. Curr Opin Genet Dev. 2017. PMID: 28363112 Review.
Cited by
-
A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors.PLoS Biol. 2021 May 25;19(5):e3001263. doi: 10.1371/journal.pbio.3001263. eCollection 2021 May. PLoS Biol. 2021. PMID: 34033645 Free PMC article.
-
Protein translation: biological processes and therapeutic strategies for human diseases.Signal Transduct Target Ther. 2024 Feb 23;9(1):44. doi: 10.1038/s41392-024-01749-9. Signal Transduct Target Ther. 2024. PMID: 38388452 Free PMC article. Review.
-
Translation stalling induced mitochondrial entrapment of ribosomal quality control related proteins offers cancer cell vulnerability.Res Sq [Preprint]. 2024 Sep 13:rs.3.rs-4899860. doi: 10.21203/rs.3.rs-4899860/v1. Res Sq. 2024. PMID: 39315278 Free PMC article. Preprint.
-
High-throughput assays to assess variant effects on disease.Dis Model Mech. 2024 Jun 1;17(6):dmm050573. doi: 10.1242/dmm.050573. Epub 2024 Jun 28. Dis Model Mech. 2024. PMID: 38940340 Free PMC article.
-
Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.J Clin Invest. 2019 Oct 1;129(10):4207-4223. doi: 10.1172/JCI127032. J Clin Invest. 2019. PMID: 31483294 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous